The presentation slides as well as the live audio broadcast may be accessed on the investor section of the Company's web site at www.alere.com. The slides will be posted shortly before the presentation begins and will remain posted for at least 30 days. An archived version of the audio broadcast also will be available through the website for at least 30 days.
Institutional investors and financial analysts who wish to attend the meeting in person must register in advance via the Events page of the Investor Center on the Company's website. Registration will open on November 18, 2010, and can be accessed using the following link:
http://investor.alere.com/investor-center/events--presentations.aspx
During the meeting, the Company may answer questions concerning business and financial developments and trends and other business and financial matters. The Company's responses to these questions, as well as other matters discussed during the briefing, may contain or constitute information that has not been previously disclosed.
For more information about Alere, please visit our website athttp://www.alere.com.
By developing new capabilities in near-patient diagnosis, monitoring and health management, Alere enables individuals to take charge of improving their health and quality of life at home. Alere's global leading products and services, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women's health. Alere is headquartered in Waltham, Massachusetts.
SOURCE Alere Inc.
